Trial Search Results
Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma
To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.
Stanford is currently not accepting patients for this trial.
Collaborator: National Institutes of Health (NIH)
- Procedure: high dose chemo then auto hematopoietic cell transplant
Inclusion Criteria:- relapsed NHL Exclusion Criteria:- liver dysfunction
Ages Eligible for Study
4 Weeks - 75 Years
Genders Eligible for Study